Frazier Management as of June 30, 2019
Portfolio Holdings for Frazier Management
Frazier Management holds 18 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 33.5 | $131M | 2.3M | 56.42 | |
| Iovance Biotherapeutics (IOVA) | 13.8 | $54M | 2.2M | 24.52 | |
| Krystal Biotech (KRYS) | 9.2 | $36M | 895k | 40.27 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 6.4 | $25M | 1.9M | 13.15 | |
| Gritstone Oncology Ord (GRTSQ) | 5.9 | $23M | 2.1M | 11.14 | |
| Translate Bio | 5.5 | $21M | 1.7M | 12.63 | |
| Millendo Therapeutics | 4.1 | $16M | 1.4M | 11.56 | |
| Allena Pharmaceuticals | 3.5 | $14M | 3.3M | 4.07 | |
| Alpine Immune Sciences | 2.8 | $11M | 2.6M | 4.21 | |
| Aptinyx | 2.7 | $11M | 3.2M | 3.34 | |
| Iterum Therapeutics | 2.7 | $11M | 1.5M | 6.88 | |
| Nabriva Therapeutics | 2.6 | $10M | 4.3M | 2.43 | |
| Entasis Therapeutics Holdings Ord | 2.2 | $8.7M | 1.3M | 6.45 | |
| Synlogic | 2.0 | $7.9M | 865k | 9.10 | |
| Sierra Oncology | 1.2 | $4.5M | 8.1M | 0.56 | |
| Kezar Life Sciences | 0.9 | $3.6M | 468k | 7.71 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.6 | $2.2M | 1.3M | 1.68 | |
| Bellicum Pharma | 0.5 | $1.8M | 1.1M | 1.70 |
